SCANCELL HLDGS

 

SCANCELL HLDGS (SCLP.L, LSE, LSE:SCLP)

SCLP Share PerformanceMore

52 week high45.240 01/06/15
52 week low22.435 02/04/15
52 week change -3.490 (-10.66%)
4 week volume3,912,348 11/06/15

Media for (SCLP)

Presenter: Dr Richard Goodfellow
02/06/2015

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Is Scancell Holdings Plc The Perfect Partner For BTG plc And Shire PLC In Your Portfolio?

Shares in pharmaceutical company, Scancell (LSE:SCLP), have fallen by as much as 10% today despite the company provid...

Scancell provides positive update on SCIB1 data

Scancell Holdings confirms further encouraging results from its on-going Phase 1/2 clinical trial of SCIB1, its DNA Immun...

SCIB1 data update in resected melanoma patients

RNS Number: 8686O Scancell Holdings Plc 02 June 2015 2 June 2015 Scancell Holdings Plc Scancell provides positive update on SCIB1 data in resected melanoma patients Median survival time of 34 and 31 months for Stage III and IV patients Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of cancer, is pleased...

Scancell - Update on SCIB1 data

Update on SCIB1 data at 2015 ASCO Annual Meeting

RNS Number: 4089N Scancell Holdings Plc 18 May 2015 18 May 2015 Scancell Holdings Plc Scancell to provide update on SCIB1 data in resected melanoma patients at 2015 ASCO Annual Meeting Scancell Holdings Plc, (AIM:SCLP) , the developer of novel immunotherapies for the treatment of cancer, today announces that the latest data from the ongoing Phase 1/2 clinic...

Poster on Moditope to be presented at AACR

RNS Number: 4991K Scancell Holdings Plc 17 April 2015 17 April 2015 Scancell Holdings Plc Moditope citrullinated peptides destroy tumours and extend survival Poster to be presented at American Association for Cancer Research Annual Meeting Scancell Holdings plc ('Scancell' or the 'Company'), the developer of novel immunotherapies for the treatment of cancer, to...

Second Price Monitoring Extn

RNS Number: 3540I Scancell Holdings Plc 24 March 2015 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The closing auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determ...

Price Monitoring Extension

RNS Number: 3520I Scancell Holdings Plc 24 March 2015 Price Monitoring Extension Today's closing auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's closing auction call be...

Fundamental DataMore

EPS-1.03
Dividend yield0 %

Users' HoldingsMore

Users who hold SCANCELL HLDGS also hold..
LLOYDS GRP.18%
PREMAITHA13%
SIRIUS MINERALS12%
TESCO9%
VODAFONE GRP.9%

Codes & Symbols

ISINGB00B63D3314
SymbolsSCLP, LSE:SCLP, SCLP.L, SCLP:LN, LON:SCLP, XLON:SCLP